Glycotargeting therapeutics
JA Hubbell, DS Wilson - US Patent 11,793,882, 2023 - Google Patents
Several embodiments of the present disclosure relate to glycotargeting therapeutics that are
useful in the treatment of transplant rejection, autoimmune disease, food allergy, and …
useful in the treatment of transplant rejection, autoimmune disease, food allergy, and …
Glycotargeting therapeutics
JA Hubbell, DS Wilson - US Patent 11,793,882, 2023 - freepatentsonline.com
Several embodiments of the present disclosure relate to glycotargeting therapeutics that are
useful in the treatment of transplant rejection, autoimmune disease, food allergy, and …
useful in the treatment of transplant rejection, autoimmune disease, food allergy, and …
Glycotargeting therapeutics
JA Hubbell, DS Wilson - US Patent App. 16/723,914, 2020 - Google Patents
Several embodiments of the present disclosure relate to glycotargeting therapeutics that are
useful in the treatment of transplant rejection, autoimmune disease, food allergy, and …
useful in the treatment of transplant rejection, autoimmune disease, food allergy, and …
GLYCOTARGETING THERAPEUTICS
JA Hubbell, DS Wilson - US Patent App. 16/723,914, 2020 - freepatentsonline.com
Several embodiments of the present disclosure relate to glycotargeting therapeutics that are
useful in the treatment of transplant rejection, autoimmune disease, food allergy, and …
useful in the treatment of transplant rejection, autoimmune disease, food allergy, and …